Skip to content

Savara SVRA Long-Term Debt

Long-Term Debt at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$221.22M+1.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$0-100%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$258.1M+0.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$286M-6.3%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$18.94M-36.9%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.57B+19.1%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+236%
Enterprise value$1.19B+224%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's long-term debt?
Savara (SVRA) reported long-term debt of $30.07M in Q1 2026.
How has Savara's long-term debt changed year-over-year?
Savara's long-term debt increased by 1.8% year-over-year, from $29.52M to $30.07M.
What is the long-term trend for Savara's long-term debt?
Over 5 years (2020 to 2025), Savara's long-term debt has grown at a 3.6% compound annual growth rate (CAGR), from $25.1M to $29.91M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.